US Cystic Fibrosis Carrier Screening Market Swells to More Than US$ 300 Million
According to a new research report by RNCOS entitled, “Genetic Testing Market Outlook to 2017”, more and more would be American parents are opting for cystic fibrosis (CF) carrier screening test to assess the chances of having a baby suffering with cystic fibrosis. The private sector is actively participating in this robust field attracted by the more than 1 Million CF carrier screening tests that are performed each year in the US. With an average reimbursement rate of US$ 200-...
View full press release